Articles

• All
• CVD
• CKD
• Dialysis
• SGLT2i
• Hypertension
• Hyperglycaemia
• AKI
• RAAS
• Anaemia
• Transplantation

• 

  Dapagliflozin after cardiac surgery: reducing AKI or reducing the diagnosis of AKI?

  1 Sep 2026

  • AKI
  • CVD
  • SGLT2i
  • Editorial

• 

  Dapagliflozin and acute kidney injury after cardiac surgery

  31 Aug 2026

  • AKI
  • CVD
  • SGLT2i

• 

  Proteomic insights into dapagliflozin in CKD

  30 Aug 2026

  • CKD
  • SGLT2i

• 

  The impact of haemodialysis on glycaemia

  29 Aug 2026

  • Dialysis
  • Hyperglycaemia

• 

  A FINE time to be a nephrologist

  30 Jun 2026

  • CKD
  • Hyperglycaemia
  • Editorial
  • CVD

• 

  Finerenone and chronic kidney disease without diabetes

  29 Jun 2026

  • CKD
  • CVD

• 

  Orforglipron versus dapagliflozin in type 2 diabetes

  28 Jun 2026

  • Hyperglycaemia

• 

  An integrated primary care model for cardiorenal-metabolic disease

  27 Jun 2026

  • CVD
  • CKD
  • Hyperglycaemia
  • Hypertension

• 

  Missed opportunities to detect and treat CKD in patients with coronary artery disease

  6 May 2026

  • Editorial
  • CKD
  • CVD